Theralase Technologies Inc. TLTFF

Primary Symbol: V.TLT

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Performance and Complaints

<< Previous

Bullboard Posts

Next >>

Comment by rollthedice10on Nov 13, 2024 2:35pm

248 Views

Post# 36310850

RE:RE:RE:Performance and Complaints

Hopefully by the time our patents expire we will be so far out front
catching up to TLT would be quite a chore. Remember a competitor
would have years of trials and FDA as well. And as I opined in a previous
post, I'm sure TLT will be applying for many more patents as well.
A competitor would have to consider TLT market share at the time
as well as any new restrictive TLT patents
before embarking on that long expensive journey. JMHO

<< Previous

Bullboard Posts

Next >>

E3 inches closer to Alberta's first lithium production plant